Tuesday, Jan 21, 2025 · SEC filings
What the smart money revealed on Jan 21
388 insider filings came in. We hid 37 planned (10b5-1) sellers and 274 people whose filings were routine, like grants and tax withholding.
Goldman Sachs Group (GS) Director Kevin Johnson bought $1.49M
2,400 shares on the open market. Not a grant or an option exercise.
Constellation Brands (STZ) Director William Giles bought $186K
1,000 shares on the open market. Not a grant or an option exercise.
Credit Suisse High Yield Bond Fund (DHY) Trustee Laura DeFelice bought $121K
56,801 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 4 checked quarters beat the typical stock 6 months later.
Credit Suisse Asset Management Income Fund (CIK) Director Laura DeFelice bought $119K
40,766 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 4 checked quarters beat the typical stock 6 months later.
Ryan Specialty (RYAN) Director Nicholas Cortezi sold $7.01M
Not marked as a planned 10b5-1 sale. Sold 40% of the shares they held directly. Still holds 155,443 shares.
Schlumberger Limited (SLB) EVP Mogharbel Al sold $5.43M
Not marked as a planned 10b5-1 sale. Sold 40% of the shares they held directly. Still holds 184,626 shares.
Mirum Pharmaceuticals (MIRM) Chief Medical Officer Joanne Quan sold $320K
Not marked as a planned 10b5-1 sale. Sold 55% of the shares they held directly. Still holds 5,649 shares.
Show 6 more real buys
Show 53 more real sales
13F season
Holdings as of Dec 31, 2024 are due Feb 14
81 funds have filed so far. 58 filed for the quarter before.
Biggest real insider buys, Jan 15–21
Open-market buys by officers and directors, filed in the 7 days up to Jan 21.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.